deerfur1
About
Nivolumab Versus Gemcitabine or Pegylated Liposomal Doxorubicin for Sufferers With Platinum-Resistant Ovarian Cancers: Open-Label, Randomized Demo within Asia (NINJA).
Nivolumab Versus Gemcitabine or Pegylated Liposomal Doxorubicin for Sufferers With Platinum-Resistant Ovarian Cancers: Open-Label, Randomized Demo within Asia (NINJA).